Paul Edward Gross serves as Executive at Clovis Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Paul Edward Gross has executed 102 insider transactions totaling $425.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 5, 2019 involved selling 237 shares valued at $6.9K.
Paul Edward Gross currently holds 95,840 shares of Clovis Oncology, Inc. (CLVS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Edward Gross has been a net seller of CLVS stock. They have purchased $0 and sold $425.0K worth of shares.
Paul Edward Gross's most recent insider trade was on Mar 5, 2019, when they sold 237 shares at $29.29 per share.
Get notified when new Form 4 filings are submitted
| $29.29 |
| Discretionary |